Safety and efficacy of the blood-stage malaria vaccine RH5.1/Matrix-M in Burkina Faso: interim results of a double-blind, randomised, controlled, phase 2b trial in children

Natama HM., Salkeld J., Somé A., Soremekun S., Diallo S., Traoré O., Rouamba T., Ouédraogo F., Ouédraogo E., Daboné KCS., Koné NA., Compaoré ZMJ., Kafando M., Bonko MDA., Konaté F., Sorgho H., Nielsen CM., Pipini D., Diouf A., King LDW., Shaligram U., Long CA., Cho J-S., Lawrie AM., Skinner K., Roberts R., Miura K., Bradley J., Silk SE., Draper SJ., Tinto H., Minassian AM.

DOI

10.1016/s1473-3099(24)00752-7

Type

Journal article

Journal

The Lancet Infectious Diseases

Publisher

Elsevier BV

Publication Date

12/2024

Permalink Original publication